University Multiprofile Hospital for Active Treatment Saint Marina - Pleven

At University Multiprofile Hospital for Active Treatment Saint Marina - Pleven, clinical trials in diagnosis focus on improving magnetic resonance imaging by comparing new contrast agents with established options. These studies aim to support clearer imaging and better assessment of patients with suspected non-central nervous system conditions.

• Improving MRI contrast performance and diagnostic accuracy
• Evaluating imaging tools for suspected internal pathology
• Supporting safer and more effective diagnostic decision-making

This research reflects the site’s interest in advancing analytical, diagnostic, and therapeutic techniques that can strengthen everyday clinical care.

Several trials at the site address nervous system diseases, especially multiple sclerosis and related inflammatory disorders. The research is centered on understanding whether new treatments can better control brain and nerve inflammation while maintaining long-term safety and tolerability.

• Relapsing forms of multiple sclerosis
• Progressive multiple sclerosis
• Chronic inflammatory demyelinating polyneuropathy

These studies support the search for more effective options for people living with chronic neurological conditions and may help refine care at Saint Marina - Pleven.

Clinical trials in cardiovascular diseases at this site examine ways to prevent stroke, reduce recurrent heart-related events, and improve protection for patients with atrial fibrillation or recent ischemic events. The overall goal is to test whether newer therapies can improve outcomes beyond current standard care.

• Atrial fibrillation
• Acute coronary syndrome
• Acute ischemic stroke and high-risk transient ischemic attack

This work highlights a strong focus on reducing clot-related complications and supporting safer long-term prevention strategies.

The site also conducts research in skin and connective tissue diseases and immune system diseases, with studies targeting chronic inflammatory skin conditions such as atopic dermatitis, plaque psoriasis, and forms of cutaneous lupus erythematosus. These trials are designed to assess whether new therapies can better control symptoms and improve quality of life.

• Moderate to severe atopic dermatitis
• Moderate to severe plaque psoriasis
• Subacute and chronic cutaneous lupus erythematosus

Research in this area combines symptom relief, disease control, and long-term treatment safety in patients with persistent inflammatory skin disorders.

Trials in hemic and lymphatic diseases include studies for chronic lymphocytic leukemia, where investigators are evaluating treatment combinations that may improve disease control in patients with additional medical conditions. The focus is on determining whether new approaches can extend progression-free survival and support better overall management.

• Chronic lymphocytic leukemia
• Previously untreated blood cancer patients with coexisting conditions
• Testing more effective treatment combinations for long-term disease control

This area shows the hospital’s involvement in practical oncology research aimed at improving outcomes in complex hematologic disease.

Research in nutritional and metabolic diseases at the site includes long-term follow-up for patients previously treated with HepaStem, with attention to safety and tolerability over time. These studies are relevant to rare and complex liver-related conditions, including urea cycle disorders, Crigler-Najjar syndrome, and fibroinflammatory liver diseases.

• Urea cycle disorders
• Crigler-Najjar syndrome
• Fibroinflammatory liver diseases

The purpose is to understand longer-term treatment effects and support safer care for patients with rare metabolic and liver conditions.

Additional studies at the hospital address immune-driven neurological disease, including chronic inflammatory demyelinating polyneuropathy. These trials are focused on evaluating whether emerging therapies can reduce relapse risk and improve disease stability in people affected by peripheral nerve inflammation.

• Chronic inflammatory demyelinating polyneuropathy
• Immune-related nerve disorders
• Assessing treatment effectiveness in chronic neurological inflammation

This adds to the site’s broader expertise in both immune system diseases and nervous system diseases.